New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

A prostate biopsy checks for prostate cancer by extracting tissue samples. A transperineal biopsy has a lower infection risk than a transrectal biopsy. Biopsy results are usually ready within about ...

Although sextant biopsy is inadequate and the current reference standard involves a minimum of 12 cores, there is a point of diminishing returns regarding the numbers of cores. We published findings ...

For those with cancer, precision oncology promises better treatment plans. It is about allowing treatments to be selected on the basis of genetic signatures, which can reveal specific tumorigenic ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...

Enhanced Detection of Druggable Mutations in Non–Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor Tissue Our study found that PZ biopsies ...

Omitting systematic biopsy in men with elevated prostate-specific antigen (PSA) levels and negative MRI results, and performing only targeted biopsy of MRI-positive lesions, eliminated more than half ...

A prostate biopsy is a procedure to remove small samples of tissue from the prostate gland. It's a method to test for prostate cancer if a prostate-specific antigen (PSA) blood test or digital rectal ...